期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

癌性贫血患者血清Hepcidin及炎症介质因子LPS和IL-6表达及其意义 被引量：17

Expression and significance of Hepcidin,LPS and IL-6 in the patients with cancer-related anemia
下载PDF
导出
摘要 目的研究Hepcidin在癌性贫血发生中的意义及其与炎症介质因子细菌脂多糖(LPS)和白细胞介素-6(IL-6)之间的关系。方法应用双抗夹心生物素-亲和素-酶联免疫吸附试验(ABC-ELISA)方法检测50例癌性贫血患者和140例无贫血癌症患者的血清Hepcidin和LPS和IL-6,并分析Hepcidin与贫血、与IL-6以及LPS之间的相关关系。结果 ①癌性贫血患者血清Hepcidin为51.99±32.56μg/L明显高于无贫血患者的36.63±31.99μg/L(P<0.01)。②癌性贫血患者血清LPS和IL-6分别为75.33±62.63μg/L和39.36±82.60ng/L,均高于无贫血患者的63.43±38.76μg/L和10.38±22.00ng/L(均为P<0.05)。③癌性贫血患者的Hepcidin与LPS呈明显的正相关关系(r=0.397,t=2.996,P<0.01);Hepcidin与IL-6也呈正相关关系(r=0.302,t=2.201,P<0.05)。④癌性贫血患者的Hepcidin、LPS和IL-6三者均与血红蛋白无相关关系。结论癌性贫血患者高表达Hepcidin、LPS和IL-6,Hepcidin与LPS和IL-6均呈正相关关系;它们在癌性贫血的发生发展过程中起重要的作用。 Objective To study the expression and significance of Hepcidin,LPS and IL-6 in patients with cancer-related anemia. Methods To test the serum levels of Hepcidin,LPS and IL-6 in 190 cases,including 50 cases with cancerrelated anemia and 140 cases of non-anemia with tumor by ABC-ELISA. Results （1）The serum levels of Hepcidin in patients with cancer-related anemia were higher than control group（51. 99±32.56 ug/L vs 36. 63 ± 31. 99 ug/L, P〈 0.01）. （2）The serum levels of LPS 和 IL-6 in patients with cancer-related anemia were 75.33±62.63 ug/L and 39.36± 82.60 ng/L respectively,which were all higher than in cases of non-anemia with tumor respectively（63.43±38.76 ug/ L and 10.38± 22.00 ng/L respectively,P〈0.05）. （3） In patients with cancer-related anemia, there were positive correlation both Hepcidin and LPS （r= 0. 397, t= 2. 996, P〈0.01）, and were positive correlation both Hepcidin and IL -6 （r=0. 302 ,t=2. 201 ,P〈0.05）. （4）In patients with cancer-related anemia,there were no correlation between Hemoglobin and Hepcidin,LPS,and IL-6 respectively. Conclusion The expression of Hepcidin,LPS and IL-6 in patients with cancer-related anemia,and there were positive correlation both Hepcidin and LPS （r=0. 397 ,t=2. 996 ,P〈0.01） ,and there were positive correlation among Hepcidin ,LPS and IL- 6）. They may be one of factors contributed the cancer-related anemia in patients with tumor.
作者 潘湘涛 陆晔 程旭 王金湖 李蓉 严敏
机构地区 苏州大学附属太仓医院血液科
出处 《中国实验诊断学》 2012年第1期55-57,共3页 Chinese Journal of Laboratory Diagnosis
基金 苏州市2009年科技发展项目(SZD0951)
关键词 HEPCIDIN 脂多糖 白介素-6 癌症 贫血 cancer-related anemia Hepcidin LPS interlukin-6 （IL- 6）
分类号 R730.5 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1Grotto HZ.Anema of cancer:an overview of mechanisms involed in its pathogenesis[J].Med Oncol,2008,25(1):12.
  • 2Sasu BJ,Li H,Rose MJ,et al.Serum hepcidin but not prohepcidin may be an effective maker for anemia of inflammation(AI)[J].Blood Cell Mol Dis,2010,45(3):238.
  • 3Guidi GC,Lechi S.Advancements in anemias related to chronic condition[J].Clin Chem Lab Med,2010,48(9):1217.
  • 4Butterfield AM,Luan P,Witcher DR,et al.A Dual-monoclonal sandwich ELISA specific for hepcidin-25[J].Clin Chem,2010,56(11):1125.
  • 5Hohaus S,Massini G,Giachelia M,et al.Anemia in Hodgkin's lymphoma:the role of interleukin-6 and hepcidin[J].J Clin Oncol,2010,28(15):2538.
  • 6Ganz T,Olbina G,Girelli D,et al.Immunoassay for human serum hepcidin[J].Blood,2008,112(10):4292.
  • 7Igor Theurl,Veren M,Markus S,t al.Dysregulaed monocyte iron homeostasis and erythropoietin formation in patients ith anemia of chronic disease[J].Blood,2006;107(10):4142.
  • 8Kanda J,Uchiyama T,Tomosugi N,et al.Oncostatin M and leukemia inhibitory factor increase hepcidin expressin in hepatoma cell lines[J].Int J Hematol,2009,90(5):545.
  • 9Kemna E,Pickkers P,Nemeh E,et al.Time-course analysis of hepcidin,serum iron,and plasma cytokine levels in muman injected with LPS[J].Blood,2005,106(5):1864.
  • 10Lee P,peng H,Gelbart T,et al.The Il-6 and lipopolysacchaide induced transcription of hepcidin in HFE,transferring receotor 2 and beta-2-microglobulin-deficient heptocytes[J].PNAS,2004,101:9263.

同被引文献98

  • 1孙雪峰,周道斌,赵永强.EPO对铁调节蛋白Hepcidin表达影响的研究[J].中国实验血液学杂志,2006,14(4):778-782. 被引量：18
  • 2D' angelo G.Role of hepcidin in the pathophysiology and diagnosis of anemia[J].Blood Res,2013,48(1):10-15.
  • 3Andriopoulos B,Corradini E,Xia Y,et al.BMP6 is a key endogenous regulator of hepeidin expression and iron metabolism[J].Nat Genet,2009,41(4):482-487.
  • 4Babitt JL,Huang FW,Wrighting DM,et at.Bone mo rphogenetic protein signaling by hemojuvelin regu-lates hepcidin expression[J].Nat Genet,2006,38(5)531-539.
  • 5Nemeth g,Tuttle MS,Powelson J,et al.Hepeidin re-gulates cellular iron effiux by binding to ferroportin and inducing its internalization[J].Science,2004,306(574):2090-2093.
  • 6Ramsay AJ,Hooper JD,Folgueras AR,et al.Matrip-tase-2(TMPRSS6):a proteolytic regulator of iron homeostasis [ J ].Haematologica,2009,94(6):840-849.
  • 7Zhang AS,Yang F,Wang J,et al.Hemojuvelin-neo-genin interaction is required for bone morphogenic protein-4-induced hepcidin expression[J].Biol Chem,2009,284(34):22580-22589.
  • 8Nemeth E,Valore EV,Territo M,et al. Hepcidin,a putative medi- ator of anemia of inflammation, is a type II acute-phhse protein [J]. Blood, 200a, 101 (7) : 2461-2463.
  • 9Krause A, Neitz S, M/igert HJ, et al. LEAP-l, a novel highly di- sulfide-bonded human peptide, exhibits antimicrobial activity[J]. FEBS Lett, 2000,480 (2) : 147-150.
  • 10Park CH, Valore EV, Waring AJ, et al. Hepcidin, a urinary anti- microbial peptide synthesized in the liver[J]. J Biol Chem, 2001, 276 (11) . 7806-7810.

引证文献17

二级引证文献37

中国实验诊断学
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部